MATTHEW TELMER: Open Payments
NPI 1760954952 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$24,030 in 60 payments from 13 companies in 2025. Trend: 2023 $1,539 · 2024 $3,952 · 2025 $24,030
Speaker / faculty: $14,902Travel & lodging: $5,062Consulting: $2,616Food & beverage: $1,365Education: $84
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 22 | $15,873 |
| Regeneron Healthcare Solutions, Inc. | 9 | $7,511 |
| Janssen Biotech, Inc. | 6 | $175 |
| Aimmune Therapeutics, Inc. | 6 | $115 |
| ABBVIE INC. | 5 | $89 |
| Regeneron Pharmaceuticals, Inc. | 1 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| PFIZER INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $25 |
Products named: DUPIXENT, TREMFYA, ZENPEP, RINVOQ, VOWST, ENTYVIO, XELJANZ, OMVOH.
Industry payments across MO — which companies pay providers there.
